XML 63 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity-Based Compensation Plans
9 Months Ended
Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Equity-Based Compensation Plans

Note 4 – Equity-Based Compensation Plans

 

At September 30, 2014, the Company had the following equity-based compensation plans:  the First Bancorp 2014 Equity Plan, the First Bancorp 2007 Equity Plan, and the First Bancorp 2004 Stock Option Plan.  The Company's shareholders approved all equity-based compensation plans.  The First Bancorp 2014 Equity Plan became effective upon the approval of shareholders on May 8, 2014.  As of September 30, 2014, the First Bancorp 2014 Equity Plan was the only plan that had shares available for future grants. 

 

The First Bancorp 2014 Equity Plan is intended to serve as a means to attract, retain and motivate key employees and directors and to associate the interests of the plans' participants with those of the Company and its shareholders.  The First Bancorp 2014 Equity Plan allows for both grants of stock options and other types of equity-based compensation, including stock appreciation rights, restricted stock, restricted performance stock, unrestricted stock, and performance units. 

 

Recent equity grants to employees have either had performance vesting conditions, service vesting conditions, or both.  Compensation expense for these grants is recorded over the various service periods based on the estimated number of equity grants that are probable to vest.  No compensation cost is recognized for grants that do not vest and any previously recognized compensation cost will be reversed.  As it relates to director equity grants, the Company grants common shares, valued at approximately $16,000, to each non-employee director (currently 11 in total) in June of each year.  Compensation expense associated with these director grants is recognized on the date of grant since there are no vesting conditions.

 

Pursuant to an employment agreement, the Company granted the chief executive officer 75,000 non-qualified stock options and 40,000 shares of restricted stock during the third quarter of 2012.  The option award and the restricted stock award will vest in full on December 31, 2014 and December 31, 2015, respectively, if the Company achieves certain earnings targets for those years, and will be forfeited if the applicable earnings targets are not achieved.  Compensation expense for this grant will be recorded over the various periods based on the estimated number of options and restricted stock that are probable to vest.  If the awards do not vest, no compensation cost will be recognized and any previously recognized compensation cost will be reversed.  Based on current conditions, the Company has concluded that it is not probable that these awards will vest, and thus no compensation expense has been recorded. 

 

Based on the Company's performance in 2013, the Company granted long-term restricted shares of common stock to the chief executive officer on February 11, 2014 with a two-year minimum vesting period.  The total compensation expense associated with the grant was $278,200 and the grant will fully vest on January 1, 2016.  One third of this value was expensed during 2013.  The Company recorded $23,200 and $69,600 in compensation expense during the three and nine months ended September 30, 2014, respectively, and expects to record $23,200 in compensation expense each quarter thereafter until the award vests.

 

The Company granted long-term restricted shares of common stock to certain senior executives on February 23, 2012 with a two year minimum vesting period.  The total compensation expense associated with this grant was $58,900 and the grant fully vested on February 23, 2014.  The Company recorded $600 and $20,000 in stock option expense related to this grant during the nine months ended September 30, 2014 and 2013, respectively.

 

Under the terms of the predecessor plans and the First Bancorp 2014 Equity Plan, options can have a term of no longer than ten years, and all options granted thus far under these plans have had a term of ten years.  The Company's options provide for immediate vesting if there is a change in control (as defined in the plans).

 

At September 30, 2014, there were 277,679 options outstanding related to the three First Bancorp plans, with exercise prices ranging from $9.76 to $22.12.  At September 30, 2014, there were 989,935 shares remaining available for grant under the First Bancorp 2014 Equity Plan. 

 

The Company issues new shares of common stock when options are exercised.

 

The Company measures the fair value of each option award on the date of grant using the Black-Scholes option-pricing model.  The Company determines the assumptions used in the Black-Scholes option pricing model as follows:  the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant; the dividend yield is based on the Company's dividend yield at the time of the grant (subject to adjustment if the dividend yield on the grant date is not expected to approximate the dividend yield over the expected life of the option); the volatility factor is based on the historical volatility of the Company's stock (subject to adjustment if future volatility is reasonably expected to differ from the past); and the weighted-average expected life is based on the historical behavior of employees related to exercises, forfeitures and cancellations.

 

The Company's equity grants for the nine months ended September 30, 2014 were the issuance of 1) 15,657 shares of long-term restricted stock to the chief executive officer on February 11, 2014, at a fair market value of $17.77 per share, which was the closing price of the Company's common stock on that date, and 2) 10,065 shares of common stock to non-employee directors on June 2, 2014 (915 shares per director), at a fair market value of $17.60 per share, which was the closing price of the Company's common stock on that date.

 

The Company's equity grants for the nine months ended September 30, 2013 were the issuance of 13,164 shares of common stock to non-employee directors on June 3, 2013 (1,097 shares per director), at a fair market value of $14.68 per share, which was the closing price of the Company's common stock on that date.

 

The Company recorded total stock-based compensation expense of $248,000 and $221,000 for the nine-month periods ended September 30, 2014 and 2013, respectively.  Of the $248,000 in expense that was recorded in 2014, approximately $177,000 related to the June 2, 2014 director grants, which is classified as “other operating expenses” in the Consolidated Statements of Income.  The remaining $71,000 in expense relates to the employee grants discussed above and is recorded as “salaries expense.”  Stock based compensation is reflected as an adjustment to cash flows from operating activities on the Company's Consolidated Statements of Cash Flows.  The Company recognized $97,000 and $86,000 of income tax benefits related to stock based compensation expense in the income statement for the nine months ended September 30, 2014 and 2013, respectively. 

 

As noted above, certain of the Company's stock option grants contain terms that provide for a graded vesting schedule whereby portions of the award vest in increments over the requisite service period.  The Company has elected to recognize compensation expense for awards with graded vesting schedules on a straight-line basis over the requisite service period for the entire award.  Compensation expense is based on the estimated number of stock options and awards that will ultimately vest.  Over the past five years, there have only been minimal amounts of forfeitures, and therefore the Company assumes that all options granted without performance conditions will become vested.

 

The following table presents information regarding the activity for the first nine months of 2014 related to all of the Company's stock options outstanding:

 

    Options Outstanding
    Number of
Shares
    Weighted-
Average
Exercise
Price
    Weighted-
Average
Contractual
Term (years)
    Aggregate
Intrinsic
Value
 
                                 
                                 

Balance at January 1, 2014

    408,408     $ 17.75                  
                                 

   Granted

   

− 

     

                 

   Exercised

   

− 

     

                 

   Forfeited

   

− 

     

                 

   Expired

    (130,729 )     21.22                  
                                 

Outstanding at September 30, 2014

    277,679     $ 16.11       4.2     $ 530,400  
                                 

Exercisable at September 30, 2014

    202,679     $ 18.46       2.9     $ 49,275  

 

The Company did not have any stock option exercises during the nine months ended September 30, 2014 or 2013.  The Company recorded no tax benefits from the exercise of nonqualified stock options during the nine months ended September 30, 2014 or 2013.

 

The following table presents information regarding the activity the first nine months of 2014 related to the Company's outstanding restricted stock:

 

    Long-Term Restricted Stock  
    Number of Units     Weighted-Average
Grant-Date Fair Value
 
                 

Nonvested at January 1, 2014

    45,374     $ 9.90  
                 

Granted during the period

    15,657       17.77  

Vested during the period

    (10,593 )     14.32  

Forfeited or expired during the period

   

̶ 

     

̶

 
                 

Nonvested at September 30, 2014

    50,438     $ 11.42